| Idorsia Pharmaceuticals Ltd - Jeraygo 12.5 mg, Filmtabletten | | 70047 | | 01 | | Jeraygo 12.5 mg | | Filmtabletten | | C02KN01 | | Aprocitentan | | 18.09.2025 | | |
| | Composition | | aprocitentanum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 54 mg, carmellosum natricum conexum corresp. natrium max. 0.36 mg, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, E 171, triethylis citras, hydroxypropylcellulosum, silica colloidalis hydrica, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Aprocitentanum | 12.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Lactose Monohydrate | 54 mg | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Hydrica | | | | Talcum | | | | Triethylis Citras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | | | B | | Oui | | 002 | 10 x 1 | | | B | | Oui |
|
|
